Sasfin's Nesan Nair talks Amplats's giant dividend and the Tiger Brands tinned food recall. Liberty Two Degrees's interims: strong in retail as office still struggles. Kea Nonyana of ThinkMarkets on Tesla results and this week's Federal Open Market Committee meeting

Supplies will also be distributed to the other African countries.

Ramaphosa hails Biovac deal to produce more than 100m doses of Pfizer-BioNTech vaccine in the Mother City.

Herenya Capital's Petri Redelinghuys talks about his market predictions for the week ahead. Novare Actuaries and Consultants's Tino Mombo offers tips on selecting the best crypto exchange for your needs – and being prepared for losses. Senwes CEO Francois Strydom unpacks the company's strong results as EPS almost doubles.

To support Aspen in producing 500m doses of the shots through 2022.

The campaign is 'so that Africa can lessen its reliance of being an importer of 99% of all its vaccines'.

Seen as another constraint or risk to growth.

CEO Hamish Erskine gives the lowdown on the launch of TradeZone 2, a 45-hectare site now open for investment next to Durban’s King Shaka International Airport.

This week MoneywebNOW looked at office rental space, commodity stocks, MTN and more.

Says drought-stricken metro must be declared a disaster area.

‘I think Aspen is one of the most operationally efficient [companies] manufacturing pharmaceuticals in the world’: Kearabilwe Nonyana, manager, equities and derivatives, ThinkMarkets.

Wayne McCurrie of FNB Wealth and Investments on miners hitting new highs. Thinkmarkets's Kearabilwe Nonyana on the investment case for Aspen. Henry Biddlecombe from Anchor Global on the tech giants' knockout results.

After resolving contract spat. Medicines regulator yet to announce when trial will resume.

The financial resources remain a concern.

Gus Attridge – adjunk-hoof, Aspen Pharmacare